Filana Therapeutics, Inc. Increase (Decrease) in Deferred Liabilities
Filana Therapeutics, Inc. (FLNA) reported Increase (Decrease) in Deferred Liabilities of -$437.00 thousand for the 12-month period ending 2013-12-31, per its 10-K filed 2016-03-03.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredLiabilities · last filed 2016-03-03
- Filana Therapeutics, Inc. increase (decrease) in deferred liabilities for the quarter ending 2012-12-31 was $0.00.
- Filana Therapeutics, Inc. increase (decrease) in deferred liabilities for fiscal 2013 was -$437.00K, a 21950.00% decline from fiscal 2012.
- Filana Therapeutics, Inc. increase (decrease) in deferred liabilities for fiscal 2012 was $2.00K, a 50.00% decline from fiscal 2011.
- Filana Therapeutics, Inc. increase (decrease) in deferred liabilities for fiscal 2011 was $4.00K.
| Period end | Increase (Decrease) in Deferred Liabilities 3 month | Increase (Decrease) in Deferred Liabilities 9 month | Increase (Decrease) in Deferred Liabilities 12 month |
|---|---|---|---|
| 2013-12-31 | -$437.00K 10-K · filed 2016-03-03 | ||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-18 | $2.00K 10-K · filed 2015-02-18 | |
| 2012-09-30 | $2.00K 10-Q · filed 2013-11-01 | ||
| 2011-12-31 | $4.00K 10-K · filed 2014-02-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |